StockDuty ← Dashboard Sep 15, 2026 08:29 AM ET
SignalFDA/Bio

GSK expands myeloma pipeline in deal worth up to $750M

GSK expands myeloma pipeline via deal worth up to $750M.

What changed
GSK expands myeloma pipeline via deal worth up to $750M.
Why it matters
GSK expands myeloma pipeline via deal worth up to $750M. — impact context not separately stored; see What changed.
Sources
eodhd
Related signals
In reversal, American Cancer Society urges routine prostate cancer screening →PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →